Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2010; 16(47): 5982-5992
Published online Dec 21, 2010. doi: 10.3748/wjg.v16.i47.5982
Figure 1
Figure 1 Meta-analysis for rebleeding at 12 mo (A), overall rebleeding (B), overall mortality (C) and mortality at 24 mo (D) for trials comparing combined endoscopic treatment (sclerotherapy or banding ligation) and β-blockers with endoscopic treatment alone. SCL: Sclerotherapy: BL: Banding ligation; BB: β-blockers; OR: Odds ratio; CI: Confidence interval.